Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tizanidine hydrochloride for migraine prophylaxis
ChiCTR2000040075Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tizanidine in migraine (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Headache index. Planned start Nov 2020; status: not yet recruiting.
02
Drugs
tizanidine
03
Conditions
migraine
Beyond the preview
Go deeper on ChiCTR2000040075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040075.